Suppr超能文献

原发性小梁切除术与引流管植入术研究的视野结果。

Visual Field Outcomes in the Primary Tube Versus Trabeculectomy Study.

机构信息

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.

出版信息

Ophthalmology. 2024 Oct;131(10):1157-1163. doi: 10.1016/j.ophtha.2024.03.026. Epub 2024 Apr 4.

Abstract

PURPOSE

To describe visual field outcomes in the Primary Tube Versus Trabeculectomy (PTVT) Study.

DESIGN

Cohort analysis.

PARTICIPANTS

A total of 155 eyes (155 subjects) randomly assigned to treatment with tube shunt surgery (n = 84) or trabeculectomy with mitomycin C (n = 71).

METHODS

The PTVT Study was a multicenter randomized clinical trial comparing the safety and efficacy of trabeculectomy and tube shunt surgery in eyes without previous intraocular surgery. Subjects underwent standard automated perimetry (SAP) at baseline and annually for 5 years. Standard automated perimetry tests were deemed reliable if the false-positive rate was ≤ 15%. Tests were excluded if visual acuity was ≤ 20/400 or loss of ≥ 2 Snellen lines from baseline because of a nonglaucomatous etiology. Linear mixed-effects models were used to compare rates of change in SAP mean deviation (MD) between the 2 groups. Intraocular pressure (IOP) control was assessed by percentage of visits with IOP < 18 mmHg and mean IOP.

MAIN OUTCOME MEASURES

Rate of change in SAP MD during follow-up.

RESULTS

A total of 730 SAP tests were evaluated (average of 4.7 tests per eye). The average SAP MD at baseline was -12.8 ± 8.3 decibels (dB) in the tube group and -12.0 ± 8.4 dB in the trabeculectomy group (P = 0.57). The mean rate of change in SAP MD was -0.32 ± 0.39 dB/year in the trabeculectomy group and -0.47 ± 0.43 dB/year in the tube group (P = 0.23). Eyes with mean IOP 14 to 17.5 mmHg had significantly faster rates of SAP MD loss compared with eyes with mean IOP < 14 mmHg (-0.59 ± 0.13 vs. -0.27 ± 0.08 dB/year; P = 0.012), and eyes with only 50% to 75% of visits with IOP < 18 mmHg had faster rates than those with 100% of visits with IOP < 18 mmHg (-0.90 ± 0.16 vs. -0.29 ± 0.08 dB/year; P < 0.001). Multivariable analysis identified older age and worse IOP control as risk factors for faster progression in both treatment groups.

CONCLUSIONS

No statistically significant difference in mean rates of visual field change was observed between trabeculectomy and tube shunt surgery in the PTVT Study. Worse IOP control was significantly associated with faster rates of SAP MD loss during follow-up. Older patients were also at risk for faster progression.

FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

摘要

目的

描述原发性引流管与小梁切除术(PTVT)研究中的视野结果。

设计

队列分析。

参与者

共有 155 只眼(155 例患者)随机分配接受引流管手术(n=84)或小梁切除术联合丝裂霉素 C(n=71)治疗。

方法

PTVT 研究是一项多中心随机临床试验,比较了原发性引流管与小梁切除术治疗无既往眼内手术史的眼的安全性和疗效。患者在基线和第 1、2、3、4、5 年接受标准自动视野计(SAP)检查。如果假阳性率≤15%,则认为 SAP 测试可靠。如果视力≤20/400 或因非青光眼病因导致基线时视力丧失≥2 行 Snellen,则排除测试。使用线性混合效应模型比较两组 SAP 平均偏差(MD)变化率。通过眼压(IOP)<18mmHg 的就诊百分比和平均 IOP 评估眼压控制情况。

主要观察指标

随访期间 SAP MD 的变化率。

结果

共评估了 730 次 SAP 测试(平均每只眼 4.7 次)。引流组 SAP MD 的基线平均水平为-12.8±8.3dB,小梁切除术组为-12.0±8.4dB(P=0.57)。小梁切除术组 SAP MD 的平均变化率为-0.32±0.39dB/年,引流组为-0.47±0.43dB/年(P=0.23)。IOP 为 14 至 17.5mmHg 的眼与 IOP<14mmHg 的眼相比,SAP MD 丧失速度更快(-0.59±0.13 vs.-0.27±0.08dB/年;P=0.012),IOP<18mmHg 的就诊百分比为 50%至 75%的眼与 IOP<18mmHg 的就诊百分比为 100%的眼相比,SAP MD 丧失速度更快(-0.90±0.16 vs.-0.29±0.08dB/年;P<0.001)。多变量分析确定年龄较大和眼压控制较差是两组治疗中视野进展更快的危险因素。

结论

在 PTVT 研究中,小梁切除术与引流管手术之间的平均视野变化率无统计学差异。眼压控制较差与随访期间 SAP MD 丧失速度加快显著相关。老年患者也有更快进展的风险。

相似文献

1
Visual Field Outcomes in the Primary Tube Versus Trabeculectomy Study.
Ophthalmology. 2024 Oct;131(10):1157-1163. doi: 10.1016/j.ophtha.2024.03.026. Epub 2024 Apr 4.
2
Visual Field Outcomes in the Tube Versus Trabeculectomy Study.
Ophthalmology. 2020 Sep;127(9):1162-1169. doi: 10.1016/j.ophtha.2020.02.034. Epub 2020 Mar 4.
3
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Ophthalmology. 2018 May;125(5):650-663. doi: 10.1016/j.ophtha.2018.02.003. Epub 2018 Feb 21.
5
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Ophthalmology. 2021 Dec;128(12):1710-1721. doi: 10.1016/j.ophtha.2021.05.023. Epub 2021 May 27.
6
Evaluating Primary Treatment for People with Advanced Glaucoma: Five-Year Results of the Treatment of Advanced Glaucoma Study.
Ophthalmology. 2024 Jul;131(7):759-770. doi: 10.1016/j.ophtha.2024.01.007. Epub 2024 Jan 9.
7
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Ophthalmology. 2020 Mar;127(3):333-345. doi: 10.1016/j.ophtha.2019.10.002. Epub 2019 Oct 9.
8
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Am J Ophthalmol. 2012 May;153(5):789-803.e2. doi: 10.1016/j.ajo.2011.10.026. Epub 2012 Jan 15.
9
Aqueous shunts for glaucoma.
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD004918. doi: 10.1002/14651858.CD004918.pub3.
10
Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.
Ophthalmology. 2011 Sep;118(9):1766-73. doi: 10.1016/j.ophtha.2011.01.047. Epub 2011 May 20.

本文引用的文献

1
Relationship between Intraocular Pressure Fluctuation and Visual Field Progression Rates in the United Kingdom Glaucoma Treatment Study.
Ophthalmology. 2024 Aug;131(8):902-913. doi: 10.1016/j.ophtha.2024.02.008. Epub 2024 Feb 13.
2
Outcomes of Glaucoma Reoperations in the Primary Tube Versus Trabeculectomy Study.
Ophthalmol Glaucoma. 2023 Jul-Aug;6(4):422-431. doi: 10.1016/j.ogla.2023.02.003. Epub 2023 Feb 22.
3
Five-Year Visual Field Outcomes of the HORIZON Trial.
Am J Ophthalmol. 2023 Jul;251:143-155. doi: 10.1016/j.ajo.2023.02.008. Epub 2023 Feb 21.
4
Multivariate Longitudinal Modeling of Macular Ganglion Cell Complex: Spatiotemporal Correlations and Patterns of Longitudinal Change.
Ophthalmol Sci. 2022 Jun 16;2(3):100187. doi: 10.1016/j.xops.2022.100187. eCollection 2022 Sep.
5
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
Ophthalmology. 2022 Dec;129(12):1344-1356. doi: 10.1016/j.ophtha.2022.07.003. Epub 2022 Jul 12.
6
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
Ophthalmology. 2022 Dec;129(12):1357-1367. doi: 10.1016/j.ophtha.2022.07.004. Epub 2022 Jul 12.
7
Rates of Glaucoma Progression Derived from Linear Mixed Models Using Varied Random Effect Distributions.
Transl Vis Sci Technol. 2022 Feb 1;11(2):16. doi: 10.1167/tvst.11.2.16.
8
Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma.
Am J Ophthalmol. 2021 Sep;229:100-107. doi: 10.1016/j.ajo.2021.03.019. Epub 2021 Mar 26.
9
Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study.
Am J Ophthalmol. 2021 Feb;222:238-247. doi: 10.1016/j.ajo.2020.05.019. Epub 2020 May 23.
10
Visual Field Outcomes in the Tube Versus Trabeculectomy Study.
Ophthalmology. 2020 Sep;127(9):1162-1169. doi: 10.1016/j.ophtha.2020.02.034. Epub 2020 Mar 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验